Cite
HARVARD Citation
Ruperto, N. et al. (n.d.). THU0579 Treating To Target with Canakinumab in Patients with Active Systemic Juvenile Idiopathic Arthritis: Results from The Long-Term Extension The Phase III Pivotal Trial. Annals of the rheumatic diseases. pp. 401-402. [Online].